Top 50 Ai Diagnostics in Asia

The startup operates an AI-based diagnostic platform that enables rapid blood analysis directly at peripheral clinics, eliminating the need for extensive maintenance and operational costs. This technology enhances diagnostic accuracy and significantly reduces the time required for obtaining test results, improving patient care in underserved areas.

The startup develops medical artificial intelligence devices that utilize big data collection, processing, and gene mutation analysis to enhance health management and disease prevention. By enabling real-time analysis of endoscopic images, the technology provides critical insights to medical practitioners, improving treatment strategies and patient outcomes.

VinBrain provides artificial intelligence solutions for medical image diagnostics, utilizing deep learning algorithms to enhance the accuracy of radiological assessments. By automating image analysis, VinBrain reduces the time required for diagnosis and improves clinical decision-making in healthcare settings.

The startup develops an AI-based decision support system specifically for the radiology industry, offering teleradiology services and radiology optimization platforms. This technology enables radiologists to manage their workload more efficiently and accelerate the diagnostic process.

Endimension develops AI-driven tools for medical image analysis that enhance diagnostic accuracy and streamline radiology reporting workflows. By automating the identification and quantification of abnormalities, their solutions improve efficiency and reduce the risk of diagnostic errors in imaging centers.

The startup provides a Diagnostics-as-a-Service platform that enables insurers, health plans, and direct-to-consumer brands to implement scalable health check programs using a network of over 1,000 accredited labs. This solution addresses the need for efficient, automated diagnostic testing and data management, enhancing patient engagement and improving health outcomes through real-time insights and streamlined logistics.

MEDHINI is a generative AI-powered software platform that provides genomics-based multimodal solutions for healthcare diagnostics, focusing on areas such as antimicrobial resistance and virtual clinical trials. The platform enhances diagnostic accuracy and accessibility in pulmonology, neurology, nephrology, cardiology, and oncology, addressing the need for affordable healthcare solutions with measurable social impact.

Aillis is developing an AI-powered medical device that enables early and accurate detection of influenza through advanced diagnostic algorithms. This technology addresses the challenge of timely identification of influenza infections, facilitating prompt treatment and reducing the spread of the virus.

Diagnostic Robotics develops a signal-agnostic artificial intelligence system that utilizes predictive analytics to enhance patient triage and monitoring for healthcare insurers, providers, and patients. The platform aims to reduce care costs and improve health outcomes by optimizing patient management and engagement in value-based care settings.

The startup has developed a diagnostic platform that utilizes cognitive assessments and brain imaging to identify early indicators of Alzheimer's disease and other dementias. By analyzing brain activity and structure, the platform enables healthcare professionals to implement personalized interventions aimed at delaying cognitive decline before symptoms manifest.

The startup develops a health monitoring device that utilizes artificial intelligence to create biomedical solutions for early disease prevention and diagnosis. This technology enhances accessibility and affordability in cardiac health diagnostics, enabling healthcare providers to identify risk factors and diseases at an earlier stage.

The startup develops a remote management platform that utilizes artificial intelligence, the Internet of Things, and predictive analytics to provide real-time clinical decision support. This technology enhances patient monitoring and early-stage diagnosis of critical diseases, aiming to improve outcomes and reduce neonatal mortality rates.

The startup operates a digital platform that integrates artificial intelligence and big data analytics to create a structured repository of patient clinical data and longitudinal health histories. This technology enhances healthcare delivery by providing organizations with actionable insights, improving patient engagement and continuity of care across various interventions and services.

The startup provides diagnostic services that deliver accurate reports for adenosine deaminase, albumin, alkaline phosphatase, and bilirubin testing using advanced analytical technologies. By making these essential diagnostic tests affordable and accessible, the company addresses the gap in quality healthcare services for the general population.

Accunai utilizes artificial intelligence to convert traditional medical health reports into smart reports, enhancing data accessibility and patient engagement for hospitals and diagnostic centers. This transformation enables healthcare providers to deliver personalized health education and analytics, improving patient outcomes and operational efficiency.

Viseur AI provides AI-powered radiology and digital pathology solutions that enhance the accuracy and speed of medical image interpretation, enabling healthcare professionals to make precise diagnoses. The platform integrates seamlessly with existing healthcare IT systems, improving diagnostic confidence and workflow efficiency while ensuring secure data handling.

FathomX develops FxMammo, an AI Assistant that utilizes machine learning algorithms to analyze mammograms, significantly reducing false positive and negative rates while streamlining the clinical workflow. The technology enhances early breast cancer detection by providing radiologists with precise, data-driven insights, thereby improving diagnostic accuracy and efficiency.

CranioCatch utilizes artificial intelligence algorithms to analyze 2D and 3D radiological images, providing rapid and accurate diagnoses for dental professionals. This technology enhances patient follow-up and treatment planning by delivering results within seconds, significantly improving the efficiency of clinical workflows.

The startup offers an AI-powered platform that diagnoses performance inconsistencies in process manufacturing and provides real-time insights and predictive diagnostics. This technology enables operators to enhance throughput, minimize energy consumption, and improve product quality while reducing operational costs.

The startup operates a surgical data platform that enhances diagnostic accuracy through robotics and laparoscopic surgery, providing 3D anatomical imaging and AI-driven surgical analysis reports. This technology enables medical professionals to manage patient complications more effectively by offering detailed insights into surgical procedures.

Qmed is a digital platform that integrates AI-powered clinical assistance with seamless medical device connectivity to enhance operational efficiency in healthcare practices. By streamlining patient flow and optimizing care delivery, Qmed addresses the challenges of fragmented healthcare processes and improves overall patient outcomes.

Hevi AI develops deep learning software that enhances the accuracy and speed of radiological interpretations, specifically for stroke diagnosis. By analyzing over one million exams, their technology significantly reduces diagnostic time and improves patient outcomes in emergency care settings.

The startup has developed an artificial intelligence-based diagnostic support system that utilizes electrocardiogram data to detect atrial fibrillation at an early stage. This automated analysis provides accuracy comparable to that of a specialist, enabling healthcare professionals to improve diagnosis and treatment for heart disease patients globally.

The startup develops an AI-based image analysis software for magnetic resonance imaging (MRI) that incorporates clinical diagnostic logic to enhance the accuracy of neurological disease diagnosis. This technology enables medical professionals to achieve early detection and staging of Alzheimer's and Parkinson's diseases, improving patient outcomes through precise identification of brain damage levels.

AstraGene manufactures in-vitro diagnostic reagents, microbiology media, and molecular biology kits to enhance the accuracy and efficiency of laboratory testing in clinical, food, and veterinary sectors. The company also offers customized AI decision support systems to improve diagnostic processes, serving approximately 150 labs across the UAE and neighboring countries.

Medantrik manufactures AI-powered diagnostic devices and a mobile application that provide personalized monitoring and management of asthma and lung conditions. The technology enhances diagnostic accuracy and enables users to manage their lung health remotely, reducing the need for frequent clinic visits.

This microbiome-based life sciences company develops healthcare solutions using big data analytics, mathematical modeling, deep learning, and AI. Their technology analyzes the human microbiome to provide insights that support individual health and well-being.

The startup develops a smart wearable device that provides cardiologists with real-time electrocardiogram data and AI-assisted analysis on mobile platforms. This technology enables accurate diagnosis and management of heart conditions, improving patient care through timely and detailed reporting.

The startup develops an artificial intelligence platform that utilizes retinal scans to predict health risks associated with cardiovascular, kidney, and eye diseases. This technology enables early detection, allowing healthcare providers to implement preventive measures in primary care settings.

The startup has developed an AI-driven healthcare data platform that aggregates and analyzes real-time health data to provide actionable insights for researchers and healthcare entities. This platform enhances symptom monitoring and risk management, leading to improved efficiency and cost reduction in healthcare research.

The startup offers an AI-driven diagnostics platform that utilizes machine learning algorithms to analyze skin images and identify various skin disorders. This technology provides dermatologists with accurate, rapid assessments, reducing the time needed for diagnosis and improving patient outcomes.

ThetaLabs AI offers a portable kiosk-based primary care clinic that integrates micro diagnostics, teleconsulting, and telemedicine, enabling rapid health assessments with over 20 tests in just 10 minutes. This solution addresses the need for accessible and affordable healthcare by providing high-accuracy diagnostics and instant doctor consultations at a fraction of traditional costs.

The startup offers a patient-centric community platform that utilizes artificial intelligence and machine learning to enhance early cancer detection and provide personalized treatment solutions. By reducing the financial burden on patients, the platform creates more accessible healing opportunities for those affected by cancer.

Aivisiontech utilizes artificial intelligence to analyze data from various imaging modalities, enhancing diagnostic accuracy in medical imaging. The company addresses the challenge of inefficient data interpretation, enabling healthcare professionals to make faster and more informed decisions.

PhenoTA utilizes advanced AI algorithms to analyze blood cell data from routine blood tests, providing detailed insights into individual health conditions. This technology enhances medical decision-making by delivering precise, actionable information that can lead to earlier diagnosis and improved patient outcomes.

Tealth provides modular software solutions that enhance patient care and streamline operations across healthcare facilities, including clinics and hospitals. By offering customizable tools tailored to specific needs, Tealth improves patient experience and operational efficiency throughout the entire patient journey.

Adiuvo Diagnostics develops a multispectral autofluorescence imaging device that utilizes machine learning algorithms for rapid, label-free disease detection, tailored for low-resource environments. This technology addresses the need for efficient early diagnosis of pathogens, skin conditions, and cancer, improving healthcare outcomes in underserved areas.

BioScan AI utilizes artificial intelligence to analyze retinal images for the early detection of systemic diseases such as Chronic Kidney Disease, Diabetic Retinopathy, and Breast Cancer, providing results in under 60 seconds. The platform offers a non-invasive screening solution that enhances accessibility and reduces the need for on-site eye care specialists, making timely health assessments more efficient and affordable.

InMed Prognostics provides an AI and machine learning-based MRI tool designed for neuro radiologists, neuro physicians, and psychiatrists. This technology enhances diagnostic accuracy by analyzing brain imaging data to identify neurological conditions more effectively.

The startup develops a clinical decision support system that analyzes biosignal data from critically ill patients to diagnose and predict serious diseases. This platform enhances clinical decision-making for healthcare professionals, enabling timely and informed medical interventions.

This startup develops precision diagnosis software that predicts molecular pathology values from MRI images. The software analyzes MRI scans to assess the effects and side effects of specific treatment drugs, enabling healthcare providers to determine drug suitability for patients with degenerative brain diseases.

The startup operates a customized medical AI platform that provides cloud-based AI medical diagnosis assistance and PACS services, enabling healthcare professionals to access diagnostic support without altering their existing workflows. This platform addresses the need for accessible and efficient medical diagnosis tools, allowing for timely decision-making in various clinical environments.

InnovXcare develops AI-driven tools for Radiology, Pathology, and Oncology to enhance diagnostic accuracy and streamline clinical workflows. The company focuses on improving access to high-quality healthcare, aiming to deliver timely and equitable patient care in India and globally.

The startup operates an AI-driven global healthcare platform that facilitates digital health services, including remote consultations, prescription delivery, and diagnostic testing. By leveraging advanced telemedicine technologies, it enables users to access personalized health recommendations and connect with healthcare professionals from anywhere.

Clinlab.AI, Inc. provides an AI-powered platform for managing Physician Office Laboratories (POLs), enabling physicians to conduct clinical chemistry, immunology, and genomic testing with precision. This solution addresses the need for efficient lab operations and enhanced clinical decision-making, allowing practices to deliver personalized patient care while minimizing upfront costs.

The startup develops a deep learning-based platform for automated digital dental systems that supports remote diagnosis through advanced medical image analysis and extensive clinical data storage. This technology enables dental clinics to enhance diagnostic accuracy and streamline treatment options, improving patient care and operational efficiency.

Amwise Diagnostic specializes in precision medicine technology that utilizes genomic profiling and biomarker analysis to tailor cancer treatment plans for individual patients. This approach enhances treatment efficacy and minimizes adverse effects by ensuring therapies are specifically matched to the unique genetic makeup of each tumor.

Qure.ai utilizes deep learning and artificial intelligence to enhance the detection and management of tuberculosis, lung cancer, and stroke through advanced medical imaging analysis. By providing rapid and accurate diagnostic support, Qure.ai improves treatment planning and patient outcomes across over 90 countries, impacting more than 25 million lives.

Xrai Digital offers at-home diagnostic services, including digital X-rays, ECGs, and Pulmonary Function Tests, delivered by trained technicians. The platform provides convenient online booking and rapid report turnaround, improving access to essential health screenings and early disease detection.

IMedis utilizes artificial intelligence algorithms to analyze medical imaging data for the early detection of cancerous lesions. The company addresses the challenge of late-stage cancer diagnosis by providing healthcare professionals with timely and accurate insights, improving patient outcomes.